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Summary
Background Post-partum family planning services can prevent maternal and child morbidity and mortality in low-
resource settings. We assessed the effect of a family planning intervention package on modern contraceptive use at 
12 months post partum in predominantly rural Burkina Faso.
Methods Yam Daabo was a two group, multi-intervention, single-blinded, cluster randomised controlled trial. Primary 
health-care centres were randomly allocated to intervention or control clusters in a 1:1 ratio with only data analysts 
masked to the allocation assignment. Interventions comprised refresher training for the provider, a counselling tool, 
supportive supervision, availability of contraceptive services 7 days a week, client appointment cards, and invitation 
letters for partners. The primary outcome was modern contraceptive prevalence at 12 months, and secondary 
outcomes were modern contraceptive prevalence at 6 weeks and 6 months post partum. Analysis was by modified 
intention to treat. Prevalence ratios were adjusted for cluster effects and baseline characteristics. This study was 
registered with the Pan-African Clinical Trials Registry (PACTR201609001784334).
Findings From July 27–Oct 17, 2016, eight clinics were randomised and 571 women were enrolled and allocated: 
286 to four intervention clusters and 285 to four control clusters. Of these, 523 completed the 12-month study exit 
interview (260 in the intervention group, 263 in the control group) and 523 were included in the intention-to-treat 
analysis. At 12 months, modern contraceptive prevalence was 55% among women who received the package and 29% 
among those who received routine care in control clusters (adjusted prevalence ratio 1∙79, 95% CI 1∙30−2∙47). 
Significant differences in modern contraceptive prevalence were also seen between intervention and control groups 
at 6 weeks (42% and 10%, respectively; adjusted prevalence ratio 3∙88, 95% CI 1∙46−10∙35) and 6 months (59% and 
24%, respectively; 2∙31, 1∙44−3∙71).
Interpretation A package of six low-technology interventions, aimed at strengthening existing primary health-care 
services and enhancing demand for these services, can effectively increase modern contraceptive use for up to a year 
post partum in rural settings in Burkina Faso and has the potential to be suitable in similar settings in this country 
and others.
Funding Government of France.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Spacing birth-to-pregnancy intervals by at least 2 years 
and birth-to-birth intervals by at least 3 years could 
prevent more than 30% of maternal and 10% of infant 
mortality.1 WHO defines post-partum family planning 
(PPFP) as the prevention of unwanted pregnancies and 
closely-spaced pregnancies during the first 12 months 
after delivery when pregnancy poses the greatest risk to 
mother and baby. Hence, the aim of PPFP services is to 
help women and couples to decide on the method they 
want to use, to initiate that method, and to continue 
use for ideally 2 years or longer, depending on their 
reproductive intentions.2
Birth-to-pregnancy intervals in 50% or more of 
pregnancies in low-income and middle-income countries 
are too short—at less than 23 months.3 The unmet 
need for family planning in the post-partum period of 
12 months is high and far exceeds the unmet need for 
family planning of women who are not in the post-
partum period. Depending on the definitions of unmet 
need for PPFP and according to estimates derived from 
Demographic and Health Survey data analysis from 
57 countries, including 32 in sub-Saharan Africa, the 
proportion of post-partum women who want to postpone 
another child for at least 2 years but are not using 
contraception ranges from 32% (risk assumed to resume 
at the end of amenorrhoea) to 62% (risk assumed to 
resume soon after birth and before the sixth week post 
partum [given that pregnancy can occur even before 
menses return]).4 With the definition that the risk is 
assumed to resume soon after birth and before the sixth 
week post partum, the unmet need the year after birth 
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was 65% in east and southern Africa and even reached 
75% in west and central Africa.4 In the footsteps of 
FP2020, a global initiative to reprioritise family planning 
as a development objective, a PPFP movement was 
initiated in 2015 to address this high unmet need.
According to the most recent Demographic and Health 
Survey data available from Burkina Faso (2010), the 
median duration of breastfeeding is 24 months 
(0·6 months for exclusive breastfeeding), the median 
post-partum sexual abstinence is 8 months, and the 
median duration of amenorrhoea is 12 months.5 The 
median birth interval is 36 months, yet 13% of babies are 
born less than 24 months after their previous sibling. 
Most women (95%) attend antenatal care and deliver 
in a health facility (66%). Postnatal care is offered to 
72% of post-partum women within 48 h of childbirth, and 
81% of children 12−23 months receive all recom mended 
vaccines. Despite this high uptake of routine reproductive, 
maternal, newborn, and child health services that offer 
frequent contact points to address the contraceptive needs 
of post-partum women and couples,6 the unmet need for 
family planning among post-partum women is high at 
89% right after birth, 50% after 6 months of amenorrhoea, 
and 21% at the end of amenorrhoea. The unmet need 
among all married women of reproductive age is also 
high at 24%.4 In 2015, data from the United Nations 
showed that maternal mortality remained high in 
Burkina Faso (371 of 100 000 live births), as did the total 
fertility rate (5·4 children per woman).7
PPFP is usually designed as an integral part of 
reproductive, maternal, newborn, and child health 
services. Although advances in access to these services 
in many sub-Saharan African countries, including 
Burkina Faso, have been observed in recent decades, 
progress is slow regarding effective post-partum 
contraceptive use.3,8,9 The evidence is often weak or 
Research in context
Evidence before this study
On Aug 11, 2018, we searched PubMed using the term 
“randomized controlled trial” combined with “postpartum” and 
“family planning” or “contraception” for publications in English 
focusing on trials in developing countries. We identified 
five trials since the last systematic review, which was published 
in 2016. All five trials were in Africa (Burkina Faso, Egypt, Kenya, 
Rwanda, and Uganda) and investigated a specific intervention. 
The urban-based Burkina Faso study showed that involving 
male partners of pregnant women in maternity care through 
group sessions targeting only men and couple counselling 
sessions before and after childbirth resulted in marginal 
differences in the use of any contraceptives at 8 months post 
partum between the intervention group (71%) and control 
group (64%), with a risk ratio of 1·10 (95% CI 1·02−1·20). 
The university hospital-based Egyptian study, which recruited 
pregnant women who were planning to space their next 
pregnancy and breastfeed for at least a year, confirmed previous 
findings: in-advance counselling and provision of emergency 
contraceptive pills had a significant effect on the proportion of 
unplanned pregnancies at 6 months post partum between the 
emergency contraceptive pill and lactational amenorrhoea 
group (0·4%) and lactational amenorrhoea only group (5·3%) 
(p=0·0001). In Kenya, the use of mobile phone short message 
service sent weekly to urban women in the antenatal and 
post-partum period did not show a difference in contraceptive 
use at 10, 16, or 24 weeks post partum. In Rwanda, 
post-partum family planning (PPFP) services integrated into 
immunisation clinics appeared to be feasible, acceptable, and 
effective in increasing modern contraceptive use (49% of 
women at baseline against 57% at endline in the intervention 
group), although it is important to note that these were 
different groups of women (in the control group, the 
proportion of women using a modern method was 58% at 
baseline and 50% at endline). The university hospital-based 
Ugandan study recruited women just after childbirth who 
wanted a contraceptive implant upon receiving comprehensive 
contraceptive counselling. Implant use at 6 months was higher 
among women who had insertion before hospital 
discharge (97%) versus those who chose to delay insertion to 
6 weeks post partum (68%; p<0·001).
Added value of this study
The Yam Daabo study did not investigate a specific 
programmatic innovation or the promotion of a particular PPFP 
method—fertility and contraceptive choices were made by the 
women and couples. This cluster-randomised controlled trial 
showed that a package of six low-technology interventions, 
designed in a participatory manner and aimed at strengthening 
routine antenatal and postnatal services in primary health 
clinics in predominantly rural settings (ie, refresher training of 
service providers, regularly scheduled and strengthened 
supportive supervision of providers, enhanced availability of 
services 7 days a week, a PPFP counselling tool, appointment 
cards for women, and invitation letters for partners), doubled 
the proportion of women using short-acting and long-acting 
reversible modern contraceptives up to 12 months post partum 
when compared with women using routine care.
Implications of all the available evidence
On the basis of the growing body of evidence on PPFP, decision 
makers can opt for different strategies to strengthen 
contraceptive use depending on health service needs, gaps, 
and opportunities of specific contexts. These strategies include 
the Yam Daabo approach, which aimed to reinforce existing 
routine services through a package of different interventions. 
Although cost-effectiveness of the package warrants further 
study, the low technology of the interventions and focus on 
strengthening existing services at the primary health-care level 
make it suitable for large-scale implementation in similar 
settings in Burkina Faso and other countries.
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incomplete in terms of study design and quality, 
intervention details, or women’s perspectives according 
to various literature reviews.10−12 Additionally, knowledge 
gaps still exist, particularly regarding studies that look 
at operationally feasible ways to integrate PPFP into 
existing antenatal care and postnatal care (eg, by 
meaningfully engaging community stakeholders).2 To 
address the high unmet need for PPFP, the objective of 
Yam Daabo (ie, “your choice” in Mooré, one of the local 
languages in Burkina Faso) was to determine the 
effectiveness of a PPFP intervention package designed 
applying participatory action research on the use of 
contraceptive methods during the first year post partum. 
In anticipation of potential dissemination of the Yam 
Daabo strategy, the trial took place in rural and urban 
settings and in two countries (ie, Burkina Faso and the 
Democratic Republic of Congo); here, we report the 
results of the Burkina Faso trial.
Methods
Study design and participants
The study was implemented in Passoré province, 
Northern Region and one of the poorest areas of 
Burkina Faso, in the rural villages of Arbole, Bagaré, 
Bouré, Gomponsom, Samba, and Tema, and the urban 
Sectors of Yako (Secteur 5 and Secteur 6). Further details 
on Burkina Faso and the study sites are provided in the 
appendix, pp 2−3.
Yam Daabo was a pragmatic two-group, cluster-
randomised, multi-intervention trial done in eight primary 
health centres, at the level of which randomisation to 
control and intervention arms occurred (see published 
protocol).13 The cluster randomised controlled trial design 
was justified by the fact that three of the six components 
of the PPFP package were not delivered directly to 
individual participants but only implemented at the 
facility level. In addition, the cluster design avoided 
potential contamination between intervention and control 
groups for the other three individual-based interventions. 
Participants randomly allocated to the intervention 
group received the PPFP intervention package whereas 
individuals randomly allocated to the control group 
received routine health care.
The study was done in centres offering reproductive, 
maternal, newborn, and child-health services. Further 
details of the sampling calculation are provided in the 
published protocol.13 Health centres were eligible if they 
offered the continuum of antenatal care, delivery, and 
postnatal care; had at least three modern contraceptive 
methods available, including a barrier method such 
as condoms, a short-term method such as pills, a 
long-term method such as intrauterine devices, and 
referrals for permanent methods; had no stock-outs of 
contraceptives during the preceding 6 months; had on 
average at least 30 deliveries per month; were situated 
within a 4 h drive from the research centre; and were 
willing to participate. All pregnant women attending the 
health centres for antenatal care were invited to 
participate in the study. They were eligible if they were 
in their third pregnancy trimester; their health and 
pregnancy situation allowed for a birth at the health 
centre; they had the intention to attend antenatal care, 
delivery, and postnatal care at the health centre; they 
were not participating in another study; and they 
provided informed consent (and assent for minors of 
<18 years old).
Randomisation and masking
The eight sites were matched in pairs according to the 
number of monthly deliveries, the ratio of health workers 
per population in the health zone, and the setting (ie, rural, 
urban). Within each of the four pairs, we randomly 
assigned a site to the intervention group or to the control 
group. This randomisation was done four times (once for 
each pair). No restriction in the randomisation process 
was required. All consecutive and eligible participants 
were included in the clusters. Due to the nature of the 
interventions, participants, health staff, research assistants 
assigned to each centre, and the rest of the research team 
members could not be masked to the cluster assignments. 
Only data analysts were masked to the allocation 
assignment (ie, they received no information about the 
cluster allocation and did not interact with the field team).
Study approval was obtained by the ethics committee 
in Burkina Faso (reference number: 2016-02-019) and 
WHO Research Ethics Review Committee, Geneva, 
Switzerland (Protocol ID RPC757). All adult participants 
provided written consent. Minors gave their informed 
assent and their respective parents or guardians their 
informed consent.
Intervention package
The rationale for our approach is based on the WHO 
seminal publication in 2013 of Programmatic strategies for 
postpartum family planning, and three other systematic 
reviews of the literature (without meta-analysis) on PPFP 
interventions in less developed countries published 
between 2014 and 2016.2,11,12,14 These documents suggest 
that the following interventions may have a positive 
effect on post-partum contraceptive uptake: counselling 
activities during antenatal care; provision of PPFP 
information, education, and counselling materials before 
women are discharged home from health facilities, 
including provision of emergency contraception backup 
for users of the lactational amenorrhoea method; 
promotion by community-based counsellors of exclusive 
breastfeeding practices before 5−6 months post partum; 
access to contraceptive methods immediately after 
childbirth, including intrauterine devices; provider 
competencies in quality counselling and the provision of 
quality services with a range of readily available products; 
and longer programmes with several contact points 
between providers and clients across the continuum of 
care versus short antenatal interventions.
See Online for appendix
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Our PPFP intervention package comprised three facility-
oriented interventions (ie, refresher training of service 
providers, regularly scheduled and strengthened sup-
portive supervision of providers, enhanced availability 
of services 7 days a week), and three individual-based 
interventions (ie, a PPFP counselling tool, appointment 
cards for women, and invitation letters for partners). 
The package was designed through participatory action 
research and the process and contents are detailed 
elsewhere.15,16 Participants received individual-based inter-
ventions during third-trimester antenatal care visits and 
postnatal care follow-up visits, according to national 
practice (typically on clinical discharge [24−48 h], at 
6 days, 6 weeks, then at months 6 and 9, before the trial 
exit at month 12 post partum).
The working hypotheses for the selection of the PPFP 
interventions to be included in the package were as 
follows. They should strengthen existing antenatal care 
and postnatal care services by means of so-called low-
dose, high-frequency interventions (which we assumed 
would be more effective than high-dose, low-frequency 
strategies that promote a specific method over another 
and restrict services to a narrow time window, such 
as before home discharge after childbirth, or during 
the 6-week postnatal care visits dedicated to PPFP); 
meaningfully engage key actors, including clients and 
providers, in the design, implementation, and research to 
better reflect field reality (including limited human 
resources and clinical capacity), and ensure its feasibility, 
sustainability, and scalability to other settings; be in line 
with national health policies; and take into consideration 
the scarcity of public resources.
The WHO team in Geneva developed the paper-based 
study case report forms with inputs from the country 
researchers who tested advanced drafts with an 
appropriate sample of mock clients from sites included 
in the formative study phase. Data were collected by 
trained research assistants, irrespective of whether 
women attended clinic visits after enrolment. Data entry 
was performed in Ouagadougou and checked in Geneva 
by use of OpenClinica (version 3.11).
Outcomes
The primary outcome was prevalence of modern 
contraceptive use at 12 months post partum (assessed on 
the first day of month 12). We amended our original 
protocol to extend the follow-up period from months 9 to 
12 post partum to allow for better comparability 
with other published research, after the initial funder’s 
research grant deadline was chosen. This extension was 
approved by Ethics Committees at WHO Headquarter 
and country level. We also report two secondary 
outcomes: prevalence of modern contraceptive use at 
6 weeks (assessed at 45 days), which coincides with the 
PPFP-dedicated visit as per national recommendations, 
and prevalence of modern contraceptive use at 6 months 
(assessed on the first day of month 6), which corresponds 
to the latest point when transition from the lactational 
amenorrhoea method to another method should occur. 
We acknowledged the limitations of using prevalence of 
modern contraceptive use as an outcome: there is 
potential for contraceptive uptake to be encouraged to 
achieve targets, without accounting for women’s or 
couples’ fertility intentions and their right to determine 
the timing and spacing of their children. 
We followed WHO recommendations for medical 
eligibility to define modern contraceptives appropriate 
up to 12 months post partum.17 We categorised modern 
contraceptives as follows: long-acting and reversible 
contraceptives, including implants and intrauterine 
devices; short-acting contraceptives, including injectable, 
pills, emergency contraception, and male and female 
condoms, among others; permanent methods (male 
and female sterilisation); and lactational amenorrhoea. 
Contraceptives were further defined as “modern and 
appropriate” and “non-modern or non-appropriate”. 
Non-modern were traditional methods, withdrawal, 
and abstinence. Non-appropriate were lactational ameno 
rrhoea if used after 6 months and calendar-based methods 
if used during the first 12 months post partum. We 
assumed that as most women breastfeed for up to 2 years, 
they would not fulfil the initiation requirement of having 
at least three regular menstrual cycles before 12 months.
Statistical analysis
The sample size was estimated on the basis of the 
following assumptions. Women in the intervention 
group wanting to limit or space their pregnancies would 
already use a modern contraceptive method at 6 months, 
when the lactational amenorrhoea method is no longer 
indicated. Therefore, although the main study outcome 
was prevalence of modern contraceptive use at 12 months 
post partum, we used country data at 6 months to set our 
sample size. The sample size was estimated with the 
2010 Demographic and Health Survey data:5 we assumed 
a 5% modern contraceptive uptake in the control group 
(based on 7% of prevalence of modern contraceptive use 
among women using traditional or modern methods at 
6 months post partum), and an increase to 20% in the 
experimental group (based on 15% of prevalence of 
modern contraceptive use among women in the general 
population, to which we added 5% given the high unmet 
need for PPFP). Assuming an intracluster (health centre) 
correlation coefficient of 0·02 (no specific evidence 
existed for its value from the literature),18 the intervention 
group and the control group had each four study sites 
with at least 60 participants per site. This number allowed 
for a statistical power of 93% to detect a difference 
of 15% to a level of significance of 5%. Assuming a 
10% participant loss to follow up, each facility recruited 
at least 70 pregnant women. This equated to a cohort 
of at least 280 pregnant women in each study arm 
(four sites with 70 participants each), and in total at least 
560 participants (appendix, pp 4–5).
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Data from all eligible participants were analysed with 
IBM SPSS Statistics (version 21.0), R (version 3.4.3), and 
WINPEPI (PEPI-for-Windows, version 11.50). Generalised 
linear mixed models (log binomial and log Poisson) were 
used to assess the effect of the package on prevalence 
ratios (PRs) of main outcomes with 95% CIs, comparing 
intervention and control groups while accounting for 
clustering and adjusting for potential confounders 
(women’s baseline characteristics that were imbalanced 
between groups). Fisher’s exact test was used for statistical 
significance of differences in outcomes between groups 
when samples were small, and models did not converge. 
WINPEPI was used to obtain a post-hoc global estimation 
of the intracluster correlation coefficient. We did a 
modified intention-to-treat analysis that included all 
women irrespective of whether they continued to visit the 
clinic after enrolment. Because women had to see a 
provider to receive the intervention package, we planned 
to do a per-protocol analysis focused on participants who 
attended all recommended follow-up visits. The study is 
registered with the Pan African Clinical Trials Registry 
(PACTR201609001784334).
Role of the funding source
The study funder had no role in study design, data 
collection, data analysis, data interpretation, or writing 
the Article. The corresponding author had full access to 
all the data in the study and had final responsibility for 
the decision to submit for publication.
Results
From July 27–Oct 17, 2016, 20 primary clinics were 
assessed for eligibility, where four clinics were randomly 
assigned to the intervention group and four to the 
control group (figure). Of 614 women asked to 
participate, 571 were enrolled in the study (286 received 
the inter vention package, 285 received routine care), of 
whom 523 (260 in the intervention group, 263 in the 
control group) completed the 12 month study exit 
interview. Timely visits and missed visits between the 
intervention and control groups differed significantly 
at 6 weeks (181 [64%] of 284 vs 96 [34%] of 283) and 
6 months (45 [16%] of 280 vs 16 [6%] of 283). No par-
ticipant in the intervention group attended all the 
recommended follow-up visits from clinic discharge to 
12 months post partum, therefore the per protocol 
analysis was not done. The time from enrolment to exit 
interview spanned from July 27, 2016, to Dec 13, 2017.
Some baseline differences were noted between the 
intervention and control clusters (table 1), including length 
of exclusive breastfeeding of last child, interpregnancy 
intervals, ability to read among male partners, and usual 
travel time needed to get to the health centre.
At 12 months post partum, prevalence of modern 
contraceptive use in the intervention arm was about twice 
that of the control arm (55% vs 29%, adjusted prevalence 
ratio [PR] 1∙79, 95% CI 1∙30–2∙47); the ratio was similar 
for both short-acting contraceptives or long-acting and 
reversible contraceptives (table 2). At 6 months, prevalence 
of modern contraceptive use (which included the 
lactational amenorrhoea method) in the intervention 
group was more than double that in the control group 
(59% vs 24%, adjusted PR 2∙31, 1∙44–3∙71) and at 6 weeks 
post partum, prevalence of modern contraceptive use 
Figure: Trial profile
20 primary clinics with maternity 
care assessed for eligibility 
8 clinics randomly assigned to 
the cluster RCT
614 women asked to participate
11 clinics enrolled
9 clinics excluded (<30 deliveries per month)
3 clinics randomly assigned to the formative phase
312 women asked to participate 
in four intervention clinics
286 women enrolled
284 women with information 
available at 6 weeks
181 women actually attended 
the visit
280 women with information 
available at 6 months 
45  women actually attended 
the visit
260 women with information 
available at 12 months
26 ineligible
26 declined to participate
2 lost to follow-up
4 lost to follow-up
6 withdrew 
1 maternal death 
10 lost to follow-up
3 interrupted the study 
(0 pregnancies)
302 women asked to participate 
in four control clinics
285 women enrolled
283 women with information 
available at 6 weeks
96 women actually attended 
the visit
283 women with information 
available at 6 months 
16  women actually attended 
the visit
263 women with information 
available at 12 months
17 ineligible
15 declined to participate
1 withdrew 
1 maternal death 
0 excluded
2 withdrew  
16 lost to follow-up
2 interrupted the study 
(2 pregnancies)
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(including lactational amenorrhoea) in the intervention 
group was four times that in the control arm (42% vs 10%, 
adjusted PR 3∙88, 1·46–10·35). No women used the 
lactational amenorrhoea method in the control group 
versus a significantly higher proportion of about one in 
ten women in the intervention group at both 6 weeks and 
6 months post partum (table 2).
In terms of the mix between methods, within each of the 
trial arms, the distribution between short-acting contra- 
ceptives and long-acting and reversible contraceptive users 
was approximatively even, with slightly more short-acting 
contraceptive users at 6 weeks and 6 months, and slightly 
more long-acting and reversible contraceptives users at 
12 months (table 2). Implant was by far the preferred 
method among long-acting and reversible contraceptives 
users (appendix). There was no male or female sterili-
sation. The post-hoc global estimation of the intracluster 
correlation coefficient was 0∙036 (0∙064 for the inter-
vention group and 0∙009 for the control group).
Discussion
Overall, our results showed that the implementation of 
a package of six low-technology PPFP interventions 





General characteristics of women
Maternal age (years) 27 (16–47) 24 (15–44)
Marital status
Married or in a relationship 282 (99%) 280 (98%)
Single, widow, separated, or 
divorced
4 (1%) 5 (2%)
Education level
Never attended school 202 (70%) 205 (72%)
Primary school 41 (14%) 40 (14%)
Secondary school 43 (15%) 40 (14%)
Beyond secondary 0 (0%) 0 (0%)
Able to read an official language 78 (27%) 91 (32%)
Living setting
Rural or urban-rural 216 (76%) 226 (80%)
Urban 70 (25%) 59 (21%)
Usual travel time to health centre
<30 min 112/269 (42%) 77/275 (28%)
30–60 min 105/269 (39%) 133/275 (48%)
>1 h 52/269 (19%) 65/275 (24%)
Employment
Housewife or farmer 230 (80%) 233 (82%)
Student 25 (9%) 21 (7%)
Business 19 (7%) 21 (7%)
Other 12 (4%) 10 (4%)
Maternity and contraception
Previous pregnancies
Yes 238/283 (84%) 228/285 (80%)
Median number 3 (0–8) 2 (0–8)
Pregnancy outcomes
Livebirth 3 (0–9) 3 (0–8)
Stillbirth 0 (0–2) 0 (0–3)
Abortion 0 (0–2) 0 (0–3)
Extra-uterine 0 (0) 0 (0–2)
Living biological children
Yes 231/238 (97%) 220/228 (97%)
Median number 3 (0–7) 2 (0–7)
Age of last child
≥2 years 218/231 (94%) 211/220 (96%)
Breastfeeding of last child 232/234 (99%) 224/227 (99%)
Length of exclusive breastfeeding (months)
<1 138/232 (60%) 144/224 (64%)
1–5 19/232 (8%) 41/224 (18%)
≥6 75/232 (32%) 39/224 (17%)
Interpregnancy interval (years)
≥2 197/237 (83%) 153/228 (67%)
<2 40/237 (17%) 75/228 (33%)





(Continued from previous column)
Current pregnancy planned 143 (50%) 160 (56%)
Contraception used during year 
before pregnancy
82 (29%) 77 (27%)
Main reason for non-use
Did not know about methods 117/204 (57%) 41/208 (20%)
Pregnancy desire 45/204 (22%) 49/208 (24%)
Partner or family opposition 12/204 (6%) 29/208 (14%)
Fear of side-effects 9/204 (4%) 25/208 (12%)
Other 21/204 (10%) 64/208 (31%)
Main contraceptive used
Injectable 42/82 (51%) 48/77 (63%)
Pill 19/82 (23%) 15/77 (20%)
Implant 17/82 (21%) 13/77 (17%)
Male condom 3/82 (4%) 1/77 (1%)
Standard day method 1/82 (1%) 0 (0%)
General characteristics of male partners*
Median age (years)† 33 (19–77) 31 (17–70)
Education level
Never attended school 189/282 (67%) 179/280 (64%)
Primary school 53/282 (19%) 63/280 (23%)
Secondary school 35/282 (12%) 37/280 (13%)
Beyond secondary 5/282 (2%) 1/280 (0%)
Able to read an official language 91/281 (32%) 145/279 (52%)
Employment
Farmer 174/281 (62%) 204/280 (73%)
Business 32/281 (11%) 20/280 (7%)
Craftsman 21/281 (8%) 7/280 (3%)
Other 54/281 (19%) 49/280 (18%)
Data are n/N (%) or median (range). *Information collected from the enrolled 
women about their partners; male partners were not interviewed directly. †n=61 
in the intervention group; n=80 in the control group. 
Table 1: Baseline characteristics of study population at enrolment
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contraceptives for up to 12 months post partum in 
women in a predominantly rural region of Burkina Faso.
In both arms, the prevalence of modern contraceptive 
use increased from 6 weeks to 6 months and remained 
relatively steady until 12 months. The prevalence of 
modern contraceptive use among participants in the 
control arm at 6 months was at a level similar to that of the 
projected prevalence for 2017 among married women 
in Burkina Faso (25%).19 In comparison, the prevalence 
among participants who received the package of 
interventions (23∙4% without the lactational amenorrhoea 
method) had reached the national prevalence among 
married women by 6 weeks, before increasing to more 
than twice the national prevalence at 6 months and 
12 months.
The modern contraceptive method mix at 12 months 
within both study arms reflected that reported in the 
general population in Burkina Faso from 2014 to 2015 
(ie, 40% implants, 35% injectables, 13% pills, 8% male 
condoms, 3% intrauterine device, and other methods).20
Our low-dose, high-frequency approach required 
women to attend the routinely recommended follow-
up visits for timely adoption of contraceptives. Client 
counselling, supported by the PPFP tool, combined 
with the provision of appointment cards, might have 
contributed to the marked differences in timely visits 
between women in the intervention and control groups 
at 6 weeks and 6 months, although the proportion 
reduced in both groups over time and no women 
attended all the follow-up visits.
As for the use of the lactational amenorrhoea method 
at 6 weeks and 6 months post partum, although there 
was a significant difference between the intervention 
and control arms, our results contrast with the 2010 
Demographic and Health Survey findings that showed 
that 25% of infants younger than 6 months were 
exclusively breastfed.5 Early supplementation rooted in 
customary practices are reported to be common21 and 
might explain our results as well as the stagnant median 
duration of exclusive breastfeeding in Burkina Faso 
(0·4 month in 1993 and 0·6 month in 2010), which 
reflects the situation in other low-income countries.22 
Also according to the 2010 Demographic and Health 
Survey, the median duration of amenorrhoea was 
12 months and suggests that breastfeeding, although 
not exclusive, must be frequent enough to induce 
amenorrhoea. Therefore, our intervention package 
covered lactational amenorrhoea benefits, requirements, 
and limitations in the PPFP counselling tool along with 
information on other effective contraceptive options. Our 
package did not include a targeted promotion of the 
lactational amenorrhoea method by health staff because 
it was not perceived as an efficient use of limited 
resources,15 although studies in sub-Saharan Africa 
showed that such promotion can increase the prevalence 
of exclusive breastfeeding (eg, through peer counsellors23 
or the Ten Steps to Successful Breastfeeding24). In fact, 
most lactational amenorrhoea method users came from 
a single intervention study site (Bouré), where the main 
service provider was found to be deeply convinced by the 
benefits of the lactational amenorrhoea method and 
counselled on it.
To our knowledge, Yam Daabo is the first study using a 
PPFP package approach in Africa. Its results add to the 
body of evidence regarding the effectiveness of various 
packages of different interventions on postpartum 
contraceptive use, which is relatively sparse. The package 
strategy has previously been shown to result in earlier 
and increased use of contraception by post-partum 
women in two studies with preintervention and 
postintervention designs that were implemented in 2002 
in Guatemala25 and in 1998 in Russia.26 They tested a 
comprehensive package of maternal and child health 
interventions, including PPFP, in the postnatal period. 
In Guatemala, the interventions took place at primary 
and secondary levels of care and comprised information 
education and counselling materials, training of 
providers, and monitoring at the facility and community 
levels; the proportion of women using a modern 
contraceptive three months after birth increased from 
18% to 25%. In Russia, the package comprised the 
provision of supplies, training providers, and quality of 
care improvement in a women’s hospital; before being 
discharged home, 65% of post-partum women adopted a 
modern contraceptive method following the intervention 
Intervention Control Adjusted prevalence 
ratio (95%CI)*
12 months (primary outcome)
Modern and appropriate methods 143/260 (55%) 76/263 (29%) 1·79 (1·30–2·47)
Long-acting or permanent methods 76/260 (30%) 44/263 (17%) 1·66 (1·17–2·35)
Short-acting methods 67/260 (26%) 32/263 (12%) 2·01 (1·18–3·43)
Non-modern or non-appropriate methods 1/260 (0%) 0/263 (0%) ··
No method 116/260 (45%) 187/263 (71%) 0·65 (0·51–0·83)
6 weeks
Modern and appropriate methods 120/284 (42%) 29/283 (10%) 3·88 (1·46–10·35)
Long-acting or permanent methods 32/284 (11%) 13/283 (5%) 2·3 (0·95–5·58)
Short-acting methods 38/284 (13%) 16/283 (6%) 2·45 (1·34–4·49)
Lactational amenorrhea method 50/284 (18%) 0/283 (0%) ··†
Non-modern or non-appropriate methods 0/284 (0%) 0/283 (0%) ··
No method 164/284 (58%) 254/283 (90%) 0·51 (0·21–1·21)
6 months
Modern and appropriate methods 164/280 (59%) 68/283 (24%) 2·31 (1·44–3·71)
Long-acting or permanent methods 59/280 (21%) 33/283 (12%) 1·65 (1·09–2·48)
Short-acting methods 70/280 (25%) 35/283 (12%) 2·05 (1·35–3·12)
Lactational amenorrhea method 35/280 (13%) 0/283 (0%) ··†
Non-modern or non-appropriate methods 0/280 (0%) 0/283 (0%) ··
No method 116/280 (41%) 215/283 (76%) 0·49 (0·26–0·92)
Data are n/N (%), unless indicated differently. Point and interval estimations were obtained using log binomial or log 
Poisson models for prevalence ratios. *Accounting for clustering and adjusted for usual travel time to health centre 
and ability to read an official language (among partners). †Fisher’s exact test, two-sided p value <0·001.
Table 2: Use of contraceptive methods at 6 weeks, 6 months, and 12 months post partum
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as compared to 0% before. Neither of the two studies had 
a longer follow-up to assess change in contraceptive use.
In contrast to theses studies, which did not directly 
focus on PPFP, and to studies investigating specific 
PPFP methods or approaches (with most of them 
assessing modern contraceptive prevalence at 6 months 
or less), our research focused on PPFP within an overall 
approach of strengthening routine antenatal care and 
postnatal care services. Moreover, modern contraceptive 
prevalence in our trial was assessed up to 12 months 
after childbirth. Our study also stands out as it did not 
investigate a specific programmatic innovation or the 
promotion of a particular PPFP method: fertility and 
contraceptive choices were up to the women and couples, 
and concentrated on primary health-care centres, given 
the growing availability of antenatal care, delivery, and 
postnatal care services at primary care level in low-
resource settings, including rural areas. This offers 
enhanced client-provider contact points to minimise 
missed health services opportunities to address the 
contraceptive needs of postpartum women and couples. 
Our study also contributes to a global (a posteriori) 
estimation of the intracluster correlation coefficient, 
which was about 0·03, somewhat larger than the 
initially-assumed value of 0·02 (under this assumption 
of 0·03, the power is above 80%).
Our trial has several limitations. First, despite being 
randomised, the study included a total of eight clusters, 
which was sufficient according to our statistical 
hypotheses but is relatively modest and therefore at 
increased risk of groups not being fully similar. 
However, when controlled for differences in baseline 
characteristics, the results did not change substantially 
(the unadjusted PR at 12 months was 1∙90). Second, the 
nature of this pragmatic facility-based trial did not allow 
blinding of participants, providers, and interviewers, 
and we cannot rule out assessment bias nor a Hawthorn 
effect. Third, although we used independent inter-
viewers, we also cannot exclude an enhanced effect size 
due to a bias towards socially desirable answers 
especially in this facility-based research. Fourth, the 
paired urban study sites were both in Yako and we 
cannot exclude intervention contamination. However, a 
Hawthorn effect, information and assessment bias, and 
contamination alone cannot contribute to the large 
contraceptive use reported at different measurement 
points. Fifth, policy makers and programme managers 
might wish to implement a single most effective 
intervention. Our trial design does not allow one to 
distinguish which intervention in the package had the 
greatest effect on contraceptive use, for which further 
research would be required. However, interventions 
were chosen based on multiple stakeholder perspectives 
and integrated into the package because they were 
perceived to be of low-technology, adapted to resource-
limited settings, while strengthening existing services 
and therefore easily feasible and replicable. Sixth, 
women using modern contraceptives at 12 months 
would require follow-up until 2 years and beyond to 
study their patterns of contraceptive use and assess 
whether they continue to be more successful in spacing 
or limiting pregnancies according to their reproductive 
choices.
The implementation of a package of six low-technology 
PPFP interventions designed in a participatory manner 
to strengthen the continuum of antenatal care and 
postnatal care services in every day care in primary health 
clinics significantly raised the proportion of women 
using the lactational amenorrhoea method up to 
6 months post partum and short-acting and long-acting 
reversible modern contraceptives up to 12 months post 
partum. The large-scale implementation of a similar 
package in similar settings could contribute to decreasing 
the unmet need for post partum family planning among 
women and couples and increasing the likelihood of 
meeting FP2020 goals.
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